Abbisko Therapeutics Co, Ltd

This Phase 3 trial is testing whether an oral medication called ABSK021 (pimicotinib) can shrink tumors and improve symptoms in adults with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous joint condition. The study will enroll 90 participants who cannot have their tum…

This study is testing a new oral drug called ABSK-011, given alongside standard immunotherapy drugs, for people with advanced liver cancer that cannot be removed by surgery. The main goals are to see if the combination is safe and if it can help shrink tumors. The study will enro…

This is the first study in people to test a new oral drug called ABSK121-NX. The main goal is to find a safe dose and see how the body processes the drug in 169 patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will also look for…